vs
Side-by-side financial comparison of CXApp Inc. (CXAI) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $1.0M, roughly 1.2× CXApp Inc.). CXApp Inc. runs the higher net margin — -544.1% vs -858.5%, a 314.4% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -38.5%). Over the past eight quarters, Lucid Diagnostics Inc.'s revenue compounded faster (7.9% CAGR vs -25.0%).
CXApp Inc. is a technology firm specializing in digital workplace experience solutions. It offers cloud-based software tools for employee engagement, office space optimization, visitor management, and hybrid work coordination, serving mid-to-large enterprises across North America, APAC and Europe.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
CXAI vs LUCD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $1.2M |
| Net Profit | $-5.6M | $-10.4M |
| Gross Margin | 86.9% | — |
| Operating Margin | -576.9% | -971.0% |
| Net Margin | -544.1% | -858.5% |
| Revenue YoY | -38.5% | 3.3% |
| Net Profit YoY | -56.7% | 16.0% |
| EPS (diluted) | — | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0M | — | ||
| Q3 25 | $1.1M | $1.2M | ||
| Q2 25 | $1.2M | $1.2M | ||
| Q1 25 | $1.2M | $828.0K | ||
| Q4 24 | $1.7M | $1.2M | ||
| Q3 24 | $1.9M | $1.2M | ||
| Q2 24 | $1.8M | $976.0K | ||
| Q1 24 | $1.8M | $1.0M |
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $-3.2M | $-10.4M | ||
| Q2 25 | $-3.1M | $-4.4M | ||
| Q1 25 | $-1.6M | $-26.9M | ||
| Q4 24 | $-3.5M | $-11.5M | ||
| Q3 24 | $-5.4M | $-12.4M | ||
| Q2 24 | $-5.3M | $-11.0M | ||
| Q1 24 | $-5.2M | $-10.6M |
| Q4 25 | 86.9% | — | ||
| Q3 25 | 89.0% | — | ||
| Q2 25 | 86.0% | — | ||
| Q1 25 | 87.7% | — | ||
| Q4 24 | 86.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 80.0% | — | ||
| Q1 24 | 82.0% | — |
| Q4 25 | -576.9% | — | ||
| Q3 25 | -343.4% | -971.0% | ||
| Q2 25 | -336.1% | -978.8% | ||
| Q1 25 | -306.0% | -1508.1% | ||
| Q4 24 | -169.7% | -1033.8% | ||
| Q3 24 | -194.3% | -997.8% | ||
| Q2 24 | -206.7% | -1146.7% | ||
| Q1 24 | -197.3% | -1078.1% |
| Q4 25 | -544.1% | — | ||
| Q3 25 | -283.4% | -858.5% | ||
| Q2 25 | -256.7% | -381.7% | ||
| Q1 25 | -132.0% | -3249.8% | ||
| Q4 24 | -213.6% | -964.2% | ||
| Q3 24 | -286.5% | -1055.5% | ||
| Q2 24 | -297.6% | -1127.6% | ||
| Q1 24 | -284.4% | -1060.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.10 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | — | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.1M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $25.8M |
| Total Assets | $32.4M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | — | ||
| Q3 25 | $5.1M | $47.3M | ||
| Q2 25 | $4.9M | $31.1M | ||
| Q1 25 | $3.9M | $25.2M | ||
| Q4 24 | $4.9M | $22.4M | ||
| Q3 24 | — | $14.5M | ||
| Q2 24 | — | $24.9M | ||
| Q1 24 | — | $24.8M |
| Q4 25 | $14.0M | — | ||
| Q3 25 | $15.2M | $25.8M | ||
| Q2 25 | $14.3M | $7.9M | ||
| Q1 25 | $15.6M | $-5.4M | ||
| Q4 24 | $15.6M | $5.4M | ||
| Q3 24 | $13.6M | $6.3M | ||
| Q2 24 | $16.3M | $16.0M | ||
| Q1 24 | $20.9M | $11.9M |
| Q4 25 | $32.4M | — | ||
| Q3 25 | $28.5M | $53.2M | ||
| Q2 25 | $29.6M | $38.7M | ||
| Q1 25 | $29.3M | $32.8M | ||
| Q4 24 | $31.8M | $30.7M | ||
| Q3 24 | — | $22.6M | ||
| Q2 24 | — | $34.1M | ||
| Q1 24 | — | $32.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.6M | $-10.9M |
| Free Cash FlowOCF − Capex | $-3.6M | — |
| FCF MarginFCF / Revenue | -355.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-10.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | $-10.9M | ||
| Q2 25 | $-3.0M | $-10.5M | ||
| Q1 25 | $-979.0K | $-12.5M | ||
| Q4 24 | $-2.7M | $-9.9M | ||
| Q3 24 | $-2.1M | $-10.2M | ||
| Q2 24 | $-1.9M | $-11.5M | ||
| Q1 24 | $-650.0K | $-12.6M |
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-984.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-668.0K | — |
| Q4 25 | -355.5% | — | ||
| Q3 25 | -248.1% | — | ||
| Q2 25 | -247.2% | — | ||
| Q1 25 | -80.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -109.3% | — | ||
| Q2 24 | -108.6% | — | ||
| Q1 24 | -36.7% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 1.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
